Page last updated: 2024-11-04

tegafur and Adenocarcinoma, Alveolar

tegafur has been researched along with Adenocarcinoma, Alveolar in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's3 (75.00)29.6817
2010's1 (25.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Harada, H1
Nishio, M1
Murakami, H1
Ohyanagi, F1
Kozuka, T1
Ishikura, S1
Naito, T1
Kaira, K1
Takahashi, T1
Horiike, A1
Nishimura, T1
Yamamoto, N1
Kobayashi, S1
Fujino, N1
Suzuki, S1
Yanai, M1
Arai, W1
Hosoya, Y1
Hyodo, M1
Yokoyama, T1
Saito, S1
Kurasina, K1
Aoki, T1
Yasuda, Y1
Nagai, H1
Tamada, K1
Okita, R1
Yamashita, M1
Nakata, M1
Teramoto, N1
Bessho, A1
Mogami, H1

Trials

1 trial available for tegafur and Adenocarcinoma, Alveolar

ArticleYear
Dose-escalation study of three-dimensional conformal thoracic radiotherapy with concurrent S-1 and cisplatin for inoperable stage III non-small-cell lung cancer.
    Clinical lung cancer, 2013, Volume: 14, Issue:4

    Topics: Adenocarcinoma; Adenocarcinoma, Bronchiolo-Alveolar; Adult; Aged; Antineoplastic Combined Chemothera

2013

Other Studies

3 other studies available for tegafur and Adenocarcinoma, Alveolar

ArticleYear
Successful treatment of refractory bronchioloalveolar carcinoma with S-1 (oral fluoropyrimidine).
    Respirology (Carlton, Vic.), 2009, Volume: 14, Issue:5

    Topics: Adenocarcinoma, Bronchiolo-Alveolar; Antimetabolites, Antineoplastic; Carcinoma, Non-Small-Cell Lung

2009
[Every-other-day TS-1 administration for recurrent or non-curative advanced gastric carcinoma].
    Gan to kagaku ryoho. Cancer & chemotherapy, 2002, Volume: 29, Issue:9

    Topics: Adenocarcinoma, Bronchiolo-Alveolar; Aged; Antimetabolites, Antineoplastic; Carcinoma, Signet Ring C

2002
Multiple ground-glass opacity in metastasis of malignant melanoma diagnosed by lung biopsy.
    The Annals of thoracic surgery, 2005, Volume: 79, Issue:1

    Topics: Adenocarcinoma; Adenocarcinoma, Bronchiolo-Alveolar; Antineoplastic Agents, Alkylating; Antineoplast

2005